Drugmakers seize on biomarkers to test the FDA’s rare disease shiftnews2025-02-03T15:52:29+00:00February 3rd, 2025|Endpoints News|
Pfizer says new colorectal cancer data could support full approval of Braftovinews2025-02-03T11:45:24+00:00February 3rd, 2025|Endpoints News|
RFK Jr. continues to evade questions on vaccines and autismnews2025-01-31T20:38:53+00:00January 31st, 2025|Endpoints News|
Vertex’s non-opioid pain drug Journavx is approved by FDAnews2025-01-30T23:07:12+00:00January 30th, 2025|Endpoints News|
FDA approves Axsome’s acute migraine treatment after 2022 rejectionnews2025-01-30T20:52:30+00:00January 30th, 2025|Endpoints News|
Exclusive: Fertility startup to begin Phase 3 study of stem cell therapy for IVFnews2025-01-29T20:27:55+00:00January 29th, 2025|Endpoints News|
Trump administration makes first comments on how it will run IRA drug negotiationsnews2025-01-29T14:23:28+00:00January 29th, 2025|Endpoints News|
Kennedy hearing updates: Trump HHS nominee faces Senatenews2025-01-29T14:00:00+00:00January 29th, 2025|Endpoints News|
AstraZeneca, Daiichi Sankyo bring Enhertu to HER2-ultralow settingnews2025-01-28T20:29:08+00:00January 28th, 2025|Endpoints News|
Ozempic label expanded to include reduced risk of worsening kidney diseasenews2025-01-28T20:27:28+00:00January 28th, 2025|Endpoints News|
